Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies

Paul R.J. Ames, Mira Merashli, Fabrizio Gentile

Research output: Contribution to journalLetter

Original languageEnglish
JournalEuropean Journal of Immunology
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • Antiphospholipid
  • Bendamustine
  • Plasma cells
  • Rituximab
  • SLE

Cite this